Karen Maguiness

An Update on the Screening, Diagnosis, Management, and Treatment of Vitamin D Deficiency in Individuals with Cystic Fibrosis: Evidence-Based Recommendations from the Cystic Fibrosis Foundation

Vin Tangpricha, Alexandra Kelly, Anne L. Stephenson et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 229 citations · Full text

Efficacy and safety of Creon® 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis

Bruce C. Trapnell, Karen Maguiness, Gavin R. Graff et al. · Journal of Cystic Fibrosis · 2009 · 71 citations · Full text

Creon® 24,000, Pancreatic Fluid Collection, Gastroenterology +3

Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: A multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study

Gavin R. Graff, Karen Maguiness, John McNamara et al. · Clinical Therapeutics · 2010 · 61 citations

New Formulation, Pancrelipase Delayed-release Capsules, Gastroenterology +5

Maximal daily dose of pancreatic enzyme replacement therapy in infants with cystic fibrosis: A reconsideration

Drucy Borowitz, Daniel Gelfond, Karen Maguiness et al. · Journal of Cystic Fibrosis · 2013 · 48 citations · Full text

Maximal Daily Dose, Gastroenterology, Pediatrics +3

Pancreatic Enzyme Supplementation in Cystic Fibrosis Patients Before and After Fibrosing Colonopathy

John C. Stevens, Karen Maguiness, J Hollingsworth et al. · Journal of Pediatric Gastroenterology and Nutrition · 1998 · 43 citations